Welch Daniel G is a director of Seagen Inc.
Person profile
Roles
Address
Durham, North Carolina
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
PROTHENA CORP PUBLIC LTD CO
23 Feb 24
3
PROTHENA CORP PUBLIC LTD CO
23 Feb 24
4
Seagen Inc.
15 Dec 23
4
Seagen Inc.
29 Aug 23
144
Seagen Inc.
28 Aug 23
144
Seagen Inc.
28 Aug 23
4
Structure Therapeutics Inc.
4 Aug 23
4
Ultragenyx Pharmaceutical Inc.
9 Jun 23
4
Seagen Inc.
2 Jun 23
4
Nuvation Bio Inc.
17 May 23
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
14 Dec 23 | SGEN Seagen | Common Stock | Sale back to company | Dispose D | Yes | No | 229 | 10,725 | 2.46 mm | 0 |
14 Dec 23 | SGEN Seagen | Common Stock | Sale back to company | Dispose D | No | No | 229 | 4,750 | 1.09 mm | 0 |
14 Dec 23 | SGEN Seagen | RSU Common stock | Sale back to company | Dispose D | No | No | 0 | 2,044 | 0.00 | 0 |
28 Aug 23 | SGEN Seagen | Common Stock | Sell | Dispose S | Yes | Yes | 209.08 | 1,610 | 336.62 k | 10,725 |
28 Aug 23 | SGEN Seagen | Common Stock | Sell | Dispose S | No | Yes | 209.01 | 1,812 | 378.73 k | 6,794 |
28 Aug 23 | SGEN Seagen | Common Stock | Sell | Dispose S | No | Yes | 209.16 | 1,503 | 314.37 k | 8,606 |
28 Aug 23 | SGEN Seagen | Common Stock | Option exercise | Acquire M | No | No | 135.63 | 1,812 | 245.76 k | 10,109 |
28 Aug 23 | SGEN Seagen | NQSO Common Stock | Option exercise | Dispose M | No | No | 135.63 | 1,812 | 245.76 k | 0 |
3 Aug 23 | GPCR Structure Therapeutics | Stock option Ordinary Shares | Other | Acquire J | Yes | No | 7.97 | 205,500 | 1.64 mm | 205,500 |
3 Aug 23 | GPCR Structure Therapeutics | Stock option Ordinary Shares | Other | Acquire J | Yes | No | 7.97 | 205,500 | 1.64 mm | 205,500 |